Hearing loss risk can be eliminated with a new version of a common antibiotic, according to the new study conducted on mice.
Aminoglycosides are commonly used as a lifesaving treatment for many serious diseases. But the effectiveness of this class of antibiotics comes with a price, which is a high risk of hearing loss. It is estimated that 20 to 60 percent of patients who take the antibiotic will experience hearing loss.